Navigation Links
Parkinson's Disease: World Drug Market 2013-2023
Date:3/4/2013

>

3. Parkinson's Disease Treatment: Market Overview 2013-2023

3.1 How Much Growth Can Be Expected in the Parkinson's Disease Market, 2013-2023?

3.1.1 Overall Market Forecast for 2012-2023

3.2 Three Franchises Held 60% of the Market in 2011

3.2.1 Mirapex Drops Back in 2011

3.2.2 Patent Protection is Nearly at an End for the Leading Drugs

3.2.3 Important Generic Launches in 2011-2012

3.3 The Three Market Leaders: Overview

3.3.1 Comtan/Stalevo: Leading Parkinson's Disease Drug

3.3.2 Requip: Leading the Dopamine Agonist Segment

3.3.3 Azilect: Set to Become Market Leader

3.3.3.1 Azilect: The First Neuroprotectant?

3.4 Leading Companies in the Parkinson's Disease Treatment Market

4. Leading National Markets, 2013-2023

4.1 The EU5 Represented the Largest Regional Parkinson's Disease Market in 20114.2 The BRIC Nations Will Be the Fastest-Growing Region in the Forecast Period4.3 The US Represents a Quarter of the Market4.3.1 Market Projection for the US, 2012-20234.4 EU5: Ageing Populations and Fiscal Restrictions4.4.1 Market Projection for the EU5 Group, 2012-20234.4.2 Breakdown of the EU5 by Country, 20114.4.3 Changes in Market Shares of the EU5 Countries, 2012-20234.4.4 Germany 2012-2023: The Largest EU5 Market4.4.5 France 2012-2023: EU5's Highest Healthcare Spender 4.4.6 UK 2012-2023: Spending Restrictions4.4.7 Spain 2012-2023: Facing Significant Cost-Containment Measures4.4.8 Italy 2012-2023: One in Five People Are Over 654.5 Japan 2012-2023: Second-Largest National Market in 20124.5.1 Market Projection for Japan, 2012-20234.6 BRIC Nations: The Rapid-Growth Area for Pharma4.6.1 Market Projection for the BRIC Nations Group 2012-2023

5. Market Segments for Treatment of Parkinson's Disease, 2013-2023

5.1
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Generic Drugs: World Market 2013-2023
2. Healthcare Innovation World Cup: Call for Breakthrough Ideas to Tackle Diabetes
3. Healthcare Innovation World Cup: Innovative Ideen zur Bekämpfung von Diabetes gesucht
4. XCHC Releases Worldwide Growth Guidance For Its Cannabinoid Treatment Centers and Formulations Targeting Critical Human Ailments, Company Acts on Own Guidance
5. Research Units Across the World go for the First 3 Tesla, Cryogen Free MRI Bench Top Scanner
6. Computed Tomography (CT): Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2018
7. Sigma-Aldrich Corporations Sigma Life Science Business to Distribute Worldwide Olink Biosciences Protein Interaction Analysis Technology
8. Neutronic Ear Introduces Worlds First Rechargeable-Powered Hearing Device
9. IDEV Announces Results from Revascularization with Supera on Real World Patients (RESTORE) Study, Demonstrating Positive Clinical Outcomes in Significantly Diseased Patients with Long Lesions
10. Randy Gaboriault of Christiana Care Health System Named Computerworld Premier 100 IT Leader
11. Market Boosted by Strong Tech Earnings: Bank of America Corp., MAP Pharmaceuticals Inc., Swingplane Ventures Inc., World Moto, Inc., Organovo Holdings, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 21, 2014 Many power shifts are ... influence of patients in the biopharmaceutical market is ... more than ever, understanding how to effectively acquire, ... is essential. According to recent ... companies spent about two-thirds of their patient-focused dollars ...
(Date:11/21/2014)... 2014 In September 2014, the staff at ... a new product development plan that started with the ... lab coat , aptly named "Vera G.," after ... the world. The new women,s designer lab coat is ... sleek envelope collar, vertical princess and high waist seaming, ...
(Date:11/21/2014)... 21, 2014  PTC Therapeutics, Inc. (NASDAQ: PTCT ... Technology Award for Vision, Innovation, and Leadership has been awarded ... This award recognizes an individual who has had a significant ... for several decades. "I am honored ... Stuart Peltz , Ph.D., CEO of PTC Therapeutics, Inc. "When ...
Breaking Medicine Technology:New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3
... 31, 2011 Polaris Group (Polaris) today announced that ... the company,s Special Protocol Assessment (SPA) for a Phase ... in patients with advanced hepatocellular carcinoma (HCC). The randomized, ... have failed prior systemic chemotherapy. The primary endpoint of ...
... 2011 Amarin Corporation plc (Nasdaq: AMRN ... cardiovascular disease, today announced that Executive Chairman and Chief ... EDT on April, 6, 2011 at the 10th Annual ... President, John Thero, will be available at the conference ...
Cached Medicine Technology:FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Group's Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma 2FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Group's Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma 3Amarin to Present at the 10th Annual Needham Healthcare Conference 2
(Date:11/22/2014)... November 22, 2014 "My friend went ... caused by the machine," said an inventor from Cambria ... to go back a second time because the first ... , She developed the patent-pending MAMO EASY to offer ... The design saves the patient from the pain normally ...
(Date:11/22/2014)... Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) that ... developed Type 2 diabetes due to its use continue ... underway in U.S. District Court, District of South Carolina, ... litigation will convene its next Status Conference on December ... Counsel for Plaintiffs and Defendants to meet and confer, ...
(Date:11/22/2014)... Eugene, OR (PRWEB) November 22, 2014 The ... addition of Roy Baroff to its team of ... lawyer, mediator, soccer player, coach, and referee. He has over ... North Carolina and beyond. , “I'm very excited to connect ... experience and sports related interests to a program with a ...
(Date:11/22/2014)... Columbus, OH (PRWEB) November 22, 2014 ... trials for AndroGel side-effects lawsuits have been scheduled ... District Court, Northern District of Illinois. U.S. District Judge ... litigation, issued a Case Management Order (CMO) on November ... as deadlines for attorneys to submit documents and other ...
(Date:11/22/2014)... Steven Reinberg HealthDay Reporter ... outcomes are better when patients are treated in an ambulance ... drugs, German researchers report. The sooner patients get the ... the outcome after a stroke, the researchers noted. For the ... first hour after stroke symptoms start, the researchers said. ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 2Health News:Special Ambulance Delivers Vital Stroke Care More Quickly 3
... shows long-term weight control is achievable, Abstract 34, ... weight and want to keep it off might benefit ... Heart,Association,s Conference on Nutrition, Physical Activity and Metabolism., ... in the,Journal of the American Medical Association., In ...
... rates in follicular non-Hodgkin lymphoma , , THURSDAY, ... chemotherapy is safe and effective for patients ... an Italian study. , It found that ... ibritumombab tiuxetan, following chemotherapy with fludarabine and ...
... 13 Weight Watchers,International, Inc. (NYSE: WTW ) ... cash dividend of $0.175 per share, which corresponds,to an ... dividend will,be payable on April 11, 2008 to shareholders ... 2008., About Weight Watchers International, Inc., Weight ...
... on display, MINNEAPOLIS, March 13 This month, ... the free, professional,counseling from QUITPLAN(R) Services to successfully quit ... Capitol. The exhibits are on display,from Sunday, March 16 ... State,Capitol near the Rotunda., "The Capitol display is ...
... March 13 Setting the foundation for,continuing the ... Clinical Services (DCS) announced today that it doubled ... of outsourced,wound care, DCS will now have 20 ... regional senior vice presidents. With approximately 300,hospital partners ...
... Md., March 13 HHS, Agency for,Healthcare Research ... new health,information technology contracts that will focus on ... using clinical,decision support. Clinical decision support helps health ... and Women,s Hospital in Boston and Yale University ...
Cached Medicine News:Health News:American Heart Association Meeting Report 2Health News:American Heart Association Meeting Report 3Health News:American Heart Association Meeting Report 4Health News:American Heart Association Meeting Report 5Health News:American Heart Association Meeting Report 6Health News:American Heart Association Meeting Report 7Health News:American Heart Association Meeting Report 8Health News:American Heart Association Meeting Report 9Health News:American Heart Association Meeting Report 10Health News:American Heart Association Meeting Report 11Health News:American Heart Association Meeting Report 12Health News:American Heart Association Meeting Report 13Health News:Radioimmunotherapy After Chemo Safe for Common Lymphoma 2Health News:Weight Watchers Declares Quarterly Dividend 2Health News:ClearWay Minnesota(SM) Celebrates QUITPLAN(R) Services at the Capitol 2Health News:ClearWay Minnesota(SM) Celebrates QUITPLAN(R) Services at the Capitol 3Health News:Diversified Clinical Services Doubles Field Management 2Health News:AHRQ Awards $5 Million to Help Integrate Clinical Decision Support Technologies Into Health Care Delivery 2
... The Ulti-Mist™ HME product line has ... from pediatrics to adults and from intubated ... offer superior humidification for both anesthesia and ... and HME/Filters provide maximum protection for patients ...
The Pall High Performance HME is a high efficiency heat and moisture exchanger, indicated to protect patients against the potential risks of ventilation with dry and cold gases....
Passive heat and moisture exchangers for respiratory applications....
Passive heat and moisture exchangers for respiratory applications....
Medicine Products: